News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Monohon Ted
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Sold 1,871 shares
@ $0.98, valued at
$1.8k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,640 shares
@ $0.72, valued at
$1.2k
|
|
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Monohon Ted (Chief Accounting Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 50,000 options to buy
@ $11.35, valued at
$567.5k
|
|
| 02/11/2021 |
4
| Monohon Ted (Chief Accounting Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 20,000 options to buy
@ $46.1, valued at
$922k
|
|
| 02/11/2021 |
3
| Monohon Ted (Chief Accounting Officer) has filed a Form 3 on Cortexyme, Inc. |
|
|